SCHEMBL5459750

SCHEMBL5459750

COc1c(N2CC3CCC(NC(=O)OC(C)(C)C)C3C2)c(F)cc2c(=O)n(N)c(=O)n(C3CC3)c12

nearest known ligand 0.55

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.37
ALDH1A1 P00352 3/20 0.37
HPGD P15428 3/20 0.37
HSD17B10 Q99714 2/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
KCNH2 Q12809 3/20 0.35
ATM Q13315 1/20 0.35
POLB P06746 1/20 0.34
PRKD3 O94806 1/20 0.34
ALOX15 P16050 1/20 0.34
OPRM1 P35372 1/20 0.34
CLK2 P49760 1/20 0.34
CLK4 Q9HAZ1 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5817926 0.91 KDM4E (0.37) KDM4EALDH1A1HPGDHSD17B10MEN1
SCHEMBL4520442 0.89 KDM4E (0.37) KDM4EALDH1A1HPGDHSD17B10MEN1
SCHEMBL4520433 0.89 KDM4E (0.37) KDM4EALDH1A1HPGDHSD17B10MEN1
SCHEMBL4520436 0.89 KDM4E (0.37) KDM4EALDH1A1HPGDHSD17B10MEN1
SCHEMBL4514173 0.88 KCNH2 (0.36) KDM4EALDH1A1HPGDHSD17B10MEN1
SCHEMBL4513382 0.88 KCNH2 (0.36) KDM4EALDH1A1HPGDHSD17B10MEN1
SCHEMBL5450718 0.82 KDM4E (0.39) KDM4EALDH1A1HPGDHSD17B10MEN1
SCHEMBL4515204 0.81 KCNH2 (0.37) KDM4EALDH1A1HPGDHSD17B10MEN1
SCHEMBL4515203 0.81 KCNH2 (0.37) KDM4EALDH1A1HPGDHSD17B10MEN1
SCHEMBL4515211 0.81 KCNH2 (0.37) KDM4EALDH1A1HPGDHSD17B10MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070191333-A1 Antibacterial agents WARNER LAMBERT COMPANY LLC 2007-08-16 US disclosed
US-20070191333-A1 Antibacterial agents WARNER LAMBERT COMPANY LLC 2007-08-16 US disclosed
EP-1687296-A1 ANTIBACTERIAL AMINOQUINAZOLIDINEDIONE DERIVATIVES Warner-Lambert Company LLC (US) 2006-08-09 EP disclosed
WO-2005049605-A1 ANTIBACTERIAL AMINOQUINAZOLIDINEDIONE DERIVATIVES WARNER-LAMBERT COMPANY LLC (US) 2005-06-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070191333-A1 Antibacterial agents MRPL21, RPN2, FBL KDM4E 4500/4885ALDH1A1 637/4885HPGD 419/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.